APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Savolitinib Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Savolitinib Tablets Market Outlook and Growth Opportunities 2026

Report ID 174034050427 December 2025196 pages

Choose your research edition.

Industry ResearchSavolitinib Tablets Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Savolitinib Tablets Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Savolitinib Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Savolitinib Tablets Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Savolitinib Tablets Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Savolitinib Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Savolitinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Savolitinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Savolitinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Savolitinib Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Savolitinib Tablets market include WuXi STA and Shanghai Hutchison Pharmaceuticals among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Savolitinib Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Savolitinib Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Savolitinib Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Savolitinib Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Savolitinib Tablets Segment by Company

WuXi STA

Shanghai Hutchison Pharmaceuticals

Savolitinib Tablets Segment by Type

100mg per Tablet

200mg per Tablet

Savolitinib Tablets Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Savolitinib Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Savolitinib Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Savolitinib Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Savolitinib Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Savolitinib Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Savolitinib Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Savolitinib Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Savolitinib Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Savolitinib Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Savolitinib Tablets industry.

Chapter 3: Detailed analysis of Savolitinib Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Savolitinib Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Savolitinib Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Savolitinib Tablets Industry Trends Table 2. Savolitinib Tablets Industry Drivers Table 3. Savolitinib Tablets Industry Opportunities and Challenges Table 4. Savolitinib Tablets Industry Restraints Table 5. Global Savolitinib Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Savolitinib Tablets Revenue Share by Company (2021-2026) Table 7. Global Savolitinib Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Savolitinib Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Savolitinib Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Savolitinib Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Savolitinib Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Savolitinib Tablets Company, Product Type & Application Table 13. Global Savolitinib Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Savolitinib Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 100mg per Tablet Table 18. Significant Companies of 200mg per Tablet Table 19. Global Savolitinib Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Savolitinib Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Savolitinib Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Savolitinib Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Savolitinib Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Savolitinib Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Savolitinib Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Savolitinib Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Savolitinib Tablets Sales Value Share by Type (2021-2026) Table 28. Global Savolitinib Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital and Clinic Table 30. Significant Companies of Retail Pharmacies Table 31. Significant Companies of Other Table 32. Global Savolitinib Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Savolitinib Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Savolitinib Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Savolitinib Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Savolitinib Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Savolitinib Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Savolitinib Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Savolitinib Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Savolitinib Tablets Sales Value Share by Application (2021-2026) Table 41. Global Savolitinib Tablets Sales Value Share by Application (2027-2032) Table 42. Global Savolitinib Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Savolitinib Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Savolitinib Tablets Sales Market Share by Region (2021-2026) Table 45. Global Savolitinib Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Savolitinib Tablets Sales Market Share by Region (2027-2032) Table 47. Global Savolitinib Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Savolitinib Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Savolitinib Tablets Sales Value Share by Region (2021-2026) Table 50. Global Savolitinib Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Savolitinib Tablets Sales Value Share by Region (2027-2032) Table 52. Global Savolitinib Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Savolitinib Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Savolitinib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Savolitinib Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Savolitinib Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Savolitinib Tablets Sales Market Share by Country (2021-2026) Table 58. Global Savolitinib Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Savolitinib Tablets Sales Market Share by Country (2027-2032) Table 60. Global Savolitinib Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Savolitinib Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Savolitinib Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Savolitinib Tablets Sales Value Market Share by Country (2027-2032) Table 64. WuXi STA Company Information Table 65. WuXi STA Business Overview Table 66. WuXi STA Savolitinib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. WuXi STA Savolitinib Tablets Product Portfolio Table 68. WuXi STA Recent Development Table 69. Shanghai Hutchison Pharmaceuticals Company Information Table 70. Shanghai Hutchison Pharmaceuticals Business Overview Table 71. Shanghai Hutchison Pharmaceuticals Savolitinib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Shanghai Hutchison Pharmaceuticals Savolitinib Tablets Product Portfolio Table 73. Shanghai Hutchison Pharmaceuticals Recent Development Table 74. Key Raw Materials Table 75. Raw Materials Key Suppliers Table 76. Savolitinib Tablets Distributors List Table 77. Savolitinib Tablets Customers List Table 78. Research Programs/Design for This Report Table 79. Authors List of This Report Table 80. Secondary Sources Table 81. Primary Sources List of Figures Figure 1. Savolitinib Tablets Product Image Figure 2. Global Savolitinib Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Savolitinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Savolitinib Tablets Sales (2021-2032) & (K Units) Figure 5. Global Savolitinib Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Savolitinib Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 100mg per Tablet Image Figure 10. 200mg per Tablet Image Figure 11. Global Savolitinib Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Savolitinib Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Savolitinib Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Savolitinib Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Savolitinib Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Savolitinib Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital and Clinic Image Figure 18. Retail Pharmacies Image Figure 19. Other Image Figure 20. Global Savolitinib Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Savolitinib Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Savolitinib Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Savolitinib Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Savolitinib Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Savolitinib Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Savolitinib Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Savolitinib Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Savolitinib Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Savolitinib Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Savolitinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Savolitinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Savolitinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Savolitinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Savolitinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Savolitinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Savolitinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Savolitinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Savolitinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Savolitinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Savolitinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Savolitinib Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Savolitinib Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg per Tablet
  • 200mg per Tablet
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • WuXi STA
  • Shanghai Hutchison Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Savolitinib Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Savolitinib Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Savolitinib Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Savolitinib Tablets Market Dynamics
  1. 2.1 Savolitinib Tablets Industry Trends
  2. 2.2 Savolitinib Tablets Industry Drivers
  3. 2.3 Savolitinib Tablets Industry Opportunities and Challenges
  4. 2.4 Savolitinib Tablets Industry Restraints
3 Savolitinib Tablets Market by Company
  1. 3.1 Global Savolitinib Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Savolitinib Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Savolitinib Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Savolitinib Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Savolitinib Tablets Company Ranking (2024-2026)
  6. 3.6 Global Savolitinib Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Savolitinib Tablets Company Product Type and Application
  8. 3.8 Global Savolitinib Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Savolitinib Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Savolitinib Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Savolitinib Tablets Market by Type
  1. 4.1 Savolitinib Tablets Type Introduction
  2. 4.1.1 100mg per Tablet
  3. 4.1.2 200mg per Tablet
  4. 4.2 Global Savolitinib Tablets Sales Volume by Type
  5. 4.2.1 Global Savolitinib Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Savolitinib Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Savolitinib Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Savolitinib Tablets Sales Value by Type
  9. 4.3.1 Global Savolitinib Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Savolitinib Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Savolitinib Tablets Sales Value Share by Type (2021-2032)
5 Savolitinib Tablets Market by Application
  1. 5.1 Savolitinib Tablets Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Savolitinib Tablets Sales Volume by Application
  6. 5.2.1 Global Savolitinib Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Savolitinib Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Savolitinib Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Savolitinib Tablets Sales Value by Application
  10. 5.3.1 Global Savolitinib Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Savolitinib Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Savolitinib Tablets Sales Value Share by Application (2021-2032)
6 Savolitinib Tablets Regional Sales and Value Analysis
  1. 6.1 Global Savolitinib Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Savolitinib Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Savolitinib Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Savolitinib Tablets Sales by Region (2027-2032)
  5. 6.3 Global Savolitinib Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Savolitinib Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Savolitinib Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Savolitinib Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Savolitinib Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Savolitinib Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Savolitinib Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Savolitinib Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Savolitinib Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Savolitinib Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Savolitinib Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Savolitinib Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Savolitinib Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Savolitinib Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Savolitinib Tablets Sales Value Share by Country, 2025 VS 2032
7 Savolitinib Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Savolitinib Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Savolitinib Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Savolitinib Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Savolitinib Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Savolitinib Tablets Sales by Country (2027-2032)
  6. 7.4 Global Savolitinib Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Savolitinib Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Savolitinib Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Savolitinib Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Savolitinib Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Savolitinib Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 WuXi STA
  2. 8.1.1 WuXi STA Company Information
  3. 8.1.2 WuXi STA Business Overview
  4. 8.1.3 WuXi STA Savolitinib Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 WuXi STA Savolitinib Tablets Product Portfolio
  6. 8.1.5 WuXi STA Recent Developments
  7. 8.2 Shanghai Hutchison Pharmaceuticals
  8. 8.2.1 Shanghai Hutchison Pharmaceuticals Company Information
  9. 8.2.2 Shanghai Hutchison Pharmaceuticals Business Overview
  10. 8.2.3 Shanghai Hutchison Pharmaceuticals Savolitinib Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Hutchison Pharmaceuticals Savolitinib Tablets Product Portfolio
  12. 8.2.5 Shanghai Hutchison Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Savolitinib Tablets Value Chain Analysis
  2. 9.1.1 Savolitinib Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Savolitinib Tablets Sales Mode & Process
  6. 9.2 Savolitinib Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Savolitinib Tablets Distributors
  9. 9.2.3 Savolitinib Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst